GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NaviFUS Corp (ROCO:6872) » Definitions » Interest Expense

NaviFUS (ROCO:6872) Interest Expense : NT$-0.43 Mil (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is NaviFUS Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. NaviFUS's interest expense for the six months ended in Dec. 2023 was NT$ -0.35 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-0.43 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. NaviFUS's Operating Income for the six months ended in Dec. 2023 was NT$ -50.49 Mil. NaviFUS's Interest Expense for the six months ended in Dec. 2023 was NT$ -0.35 Mil. NaviFUS did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


NaviFUS Interest Expense Historical Data

The historical data trend for NaviFUS's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NaviFUS Interest Expense Chart

NaviFUS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial -0.03 -0.02 -0.03 -0.01 -0.43

NaviFUS Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.01 -0.01 - -0.08 -0.35

NaviFUS Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-0.43 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NaviFUS  (ROCO:6872) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

NaviFUS's Interest Expense for the six months ended in Dec. 2023 was NT$-0.35 Mil. Its Operating Income for the six months ended in Dec. 2023 was NT$-50.49 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was NT$25.84 Mil.

NaviFUS's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

NaviFUS did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


NaviFUS (ROCO:6872) Business Description

Traded in Other Exchanges
N/A
Address
No.246, Sec 3, Chengde Road, 12th Floor, Datong District, Taipei City, TWN, 103
NaviFUS Corp is a Biotech company providing novel platform solutions for crossing the blood-brain barrier (BBB) for enhanced oncology drug delivery. Its product, the NaviFUS System, is designed to utilize non-invasive ultrasound energy to enable transient and safe enhancement of BBB permeability to facilitate the transport of small or large molecular CNS drugs to target tumor tissue at high precision for better treatment outcomes. Its vision is to cater to CNS disease patients locally and globally by bringing therapeutic ultrasound technology to clinical use.

NaviFUS (ROCO:6872) Headlines

No Headlines